You're viewing a public preview of Corstasis Therapeutics, Inc. Sign up free to access full investment history, financials, executives & more
Sign Up Free Log In

Corstasis Therapeutics, Inc.

Active
3535 Executive Terminal Dr. Suite 110,  Henderson,  Nevada (NV),  89052,  United States
(702) 541-9222
Sector: Life Science Entity: Private Founded: 2019
2019
Founded
Year established
1
Transactions
Sign up to view
$75M
Deal Value
Sign up to view
About Corstasis Therapeutics, Inc.
Corstasis Therapeutics Inc. is a biotechnology company focused on the development of therapies for rare kidney diseases. The company’s research activities center on novel drug candidates intended to address inherited and progressive renal disorders, including conditions affecting pediatric and adult patient populations. Corstasis conducts clinical-stage development programs and works within the regulatory framework governing pharmaceutical research and development in the United States. The company was founded in 2019 and is headquartered in Boston, Massachusetts, United States.
Investors
Current Investors
Esperion Therapeutics, Inc. ••••••••
Past Investors
•••••••• ••••••••
View Full Investor List
Sign up to see all current & past investors with deal dates and transaction details
Sign Up Free Log In
Investment Details
1 Transactions
Trans. IDInvestment DateExit DateInvestor(s)Deal Size (M)Seller(s)
Access 1 Transaction
Sign up to view the full investment history — dates, deal sizes, investors & sellers
Sign Up Free Log In
Corstasis Therapeutics, Inc. M&A Activity
# Company Transaction Date Close Date Sector Country
View M&A Acquisitions
Sign up to explore the full acquisition & merger history
Sign Up Free Log In
Key Executives & Professionals
View Executives & Professionals
Sign up to access board members, senior management & key contacts
Sign Up Free Log In
Frequently Asked Questions
What does Corstasis Therapeutics, Inc. do?
Corstasis Therapeutics Inc. is a biotechnology company focused on the development of therapies for rare kidney diseases. The company’s research activities center on novel drug candidates intended to address inherited and progressive renal disorders, including conditions affecting pediatric and adu
Where is Corstasis Therapeutics, Inc. headquartered?
Corstasis Therapeutics, Inc. is headquartered in Henderson, Nevada (NV), United States.
When was Corstasis Therapeutics, Inc. founded?
Corstasis Therapeutics, Inc. was founded in 2019.
What sector is Corstasis Therapeutics, Inc. in?
Corstasis Therapeutics, Inc. operates in the Life Science sector.
Who are the investors in Corstasis Therapeutics, Inc.?
Current investors in Corstasis Therapeutics, Inc. include Esperion Therapeutics, Inc.. Sign up to AcquityData to view full investor details, deal dates and transaction history.
How many M&A transactions has Corstasis Therapeutics, Inc. been involved in?
Corstasis Therapeutics, Inc. has 1 transaction tracked on AcquityData. Sign up to view full investment history including dates, deal sizes, investors and sellers.

Unlock the full Corstasis Therapeutics, Inc. profile

Ownership & Investors M&A History Financials Key Executives Advisors & Lenders

Access Corstasis Therapeutics, Inc.'s complete ownership history, M&A activity, investors, advisors and executives in one connected platform.

Start Free Trial